Corporate
Description
  • Value proposition

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP


    in vitro diagnostics, infectious diseases, reagents, automated instruments, medical analysis, cosmetics, pharmaceutical, industries, healthcare associated infections, molecular biology, microbiology, immunoassays, antimicrobial stewardship, rapid diagnostics, food safety, veterinary diagnostics, blood bank, and sepsis

  • Original language

    Pioneering Diagnostics

    Pioneering Diagnostics

    A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors.

    In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France.

    bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety.

    Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.

    bioMérieux is listed on the Euronext Paris stock market.

    Symbol: BIM – ISIN Code: FR0013280286
    Reuters: BIOX.PA/Bloomberg: BIM.FP

Entity interactions BETA
Entity TypeTweets Articles
European Society for Paediatric Infectious Diseases - ESPID European Society for Paediatric Infectious Diseases - ESPID
healthtech, Hospitals and Health Care
Other

25 May 2021


Toulouse School of Economics Toulouse School of Economics
Higher Education, edtech
Other

7 Jan 2022

17 Oct 2023



INSTITUT MÉRIEUX INSTITUT MÉRIEUX
deeptech, healthtech, Government Administration
Other

12 Oct 2021

8 Oct 2024



Crain Communications Crain Communications
Book and Periodical Publishing
Other

24 Jan 2017


IMRA Europe S.A.S. IMRA Europe S.A.S.
manufacturing, deeptech, transporttech, Motor Vehicle Manufacturing
Not capitalistic
Partnership
Event

18 Nov 2021


Festival de La Chaise-Dieu Festival de La Chaise-Dieu
entertainment, Artists and Writers
Other

1 Mar 2018


Musée des Confluences Musée des Confluences
entertainment, Museums, Historical Sites, and Zoos
Other

10 Mar 2022

9 Jun 2024



Ontario Genomics Ontario Genomics
biotech, deeptech, Research Services
Other

14 Apr 2022


Health Innovation Oxford & Thames Valley Health Innovation Oxford & Thames Valley
Hospitals and Health Care
Other

24 Feb 2022


European Pharmaceutical Review European Pharmaceutical Review
Pharmaceutical Manufacturing
Other

24 Jan 2022

19 Aug 2024



Radars
Loading...